323-606-9904 the Holistic Sanctuary, Ibogaine, Heroin Addiction Treatment Detox and Cure
323-606-9904 The Holistic Sanctuary, Ibogaine, Heroin Addiction Treatment Detox And Cure – Johnny Tabaie, a “Cured” addict, owns an ibogaine clinic in Baja California, Mexico. TheHolisticSanctuary.com Tabaie, fed up with western medicine, received an ibogaine treatment in 2007. Sine then he’s helped almost 80 people kick their addiction to heroin and other substances. He also has an astonishing 90% success rate. (For those who stay 30 days or more) We spoke to the 39-year-old Tabaie via Skype while Michael was in his care. He says a 7 to 10 day stay at his clinic will cost about 000. Longer stays are available but cost extra. A team of doctors and nurses look after his patient’s because Tabaie does not practice medicine. Once his doctor’s finish administering the ibogaine treatment they go to Tabaie and he helps “cleanse their body”, “reverse damages to the brain and immune system”. ” My job as a healer is to teach people how to “reconnect with their soul” , “end negative thought patterns”, “change their life style”, “live a better life and make better choices, ” says Tabaie. During the interview with Tabaie, Michael was off camera, just a few feet away. We did not speak with him but Tabaie assured us his treatment worked and it worked well. ” It’s unbelievable. It’s absolutely magical. It’s miraculous.” We met Michael at his home, just a few days after he returned from his ibogaine treatment. Michael had been clean for almost two weeks during this interview. He says 15-minutes after taking ibogaine he felt relief. However, his journey with ibogaine was just …
Statins may be linked to cancer survival
Filed under: drug treatment news 2012
NEW YORK | Wed Nov 7, 2012 5:05pm EST. NEW YORK (Reuters Health) – Danish cancer patients taking cholesterol-lowering statin drugs were 15 percent less likely to die, of cancer or any other cause, than patients who were not on the popular medications …
Read more on Reuters
FDA speeds review of ImmunoGen-Roche cancer drug
Filed under: drug treatment news 2012
The U.S. Food and Drug Administration has granted priority review to an investigational breast cancer treatment that is being developed by Genentech and ImmunoGen Inc. (NASDAQ:IMGN) , the companies said. The drug, trastuzumab emtansine, is in global …
Read more on MarketWatch